Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.2% |
| 2 | Healthcare | 13.65% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Consumer Staples | 11.26% |
| 5 | Industrials | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
AtriCure
ATRC
$2.22B
| $592K | ﹤0.01% |
+31,700
| New | +$461K |
|
2302
Arrowhead Research
ARWR
$12.1B
| $590K | ﹤0.01% |
+54,400
| New | +$435K |
|
|
HGT
2303
DELISTED
Hugoton Royalty Trust
HGT
| $589K | ﹤0.01% |
+78,511
| New | +$577K |
|
|
RBY
2304
DELISTED
RUBICON MENERALS CORP (F)
RBY
| $588K | ﹤0.01% |
663,800
+323,200
| +95% | +$356K |
|
|
LNBB
2305
DELISTED
L N B BANCORP INC
LNBB
| $587K | ﹤0.01% |
58,514
+17,414
| +42% | +$171K |
|
2306
Kite Realty
KRG
$5.27B
| $586K | ﹤0.01% |
22,300
-66,625
| -75% | -$1.7M |
|
|
RBS.PRF.CL
2307
DELISTED
Royal Bk Of Scotland Gp
RBS.PRF.CL
| $585K | ﹤0.01% |
23,500
+2,100
| +10% | +$52.1K |
|
2308
Enterprise Financial Services Corp
EFSC
$2.41B
| $582K | ﹤0.01% |
28,497
+15,497
| +119% | +$287K |
|
|
AKRX
2309
DELISTED
Akorn Inc
AKRX
| $581K | ﹤0.01% |
+23,600
| New | +$533K |
|
2310
PAR Technology
PAR
$770M
| $579K | ﹤0.01% |
106,200
+1,200
| +1% | +$6.45K |
|
|
FWDI
2311
Forward Industries Inc
FWDI
$305M
| $576K | ﹤0.01% |
37,170
+240
| +0.6% | +$3.97K |
|
2312
Gaia
GAIA
$33.3M
| $573K | ﹤0.01% |
86,600
-11,400
| -12% | -$68.6K |
|
2313
Stabilis Solutions
SLNG
$102M
| $573K | ﹤0.01% |
7,175
+887
| +14% | +$60K |
|
|
ITI
2314
DELISTED
Iteris, Inc.
ITI
| $573K | ﹤0.01% |
272,700
+50,600
| +23% | +$103K |
|
|
STNR
2315
DELISTED
STEINER LEISURE LTD
STNR
| $560K | ﹤0.01% |
11,391
+7,900
| +226% | +$448K |
|
|
HKTV
2316
DELISTED
HONG KONG TELEVISION NETWORK LTD
HKTV
| $559K | ﹤0.01% |
62,000
-10,900
| -15% | -$66.8K |
|
|
SYNC
2317
DELISTED
Synacor, Inc.
SYNC
| $557K | ﹤0.01% |
227,300
+86,700
| +62% | +$221K |
|
2318
AmeriServ Financial
ASRV
$84.3M
| $556K | ﹤0.01% |
183,500
+2,100
| +1% | +$6.48K |
|
2319
SIFCO Industries
SIF
$124M
| $553K | ﹤0.01% |
19,700
+700
| +4% | +$16K |
|
|
BRKL
2320
DELISTED
Brookline Bancorp
BRKL
| $552K | ﹤0.01% |
57,772
-262,114
| -82% | -$2.39M |
|
|
AMID
2321
DELISTED
American Midstream Partners, LP
AMID
| $552K | ﹤0.01% |
20,400
+1,200
| +6% | +$27.8K |
|
|
TAOM
2322
DELISTED
TAOMEE HLDGS LTD SPON ADR (CYM)
TAOM
| $550K | ﹤0.01% |
108,900
+4,900
| +5% | +$26K |
|
|
PNTR
2323
DELISTED
Pointer Telocation Ltd.
PNTR
| $549K | ﹤0.01% |
46,400
+28,100
| +154% | +$202K |
|
2324
Key Tronic
KTCC
$42.8M
| $548K | ﹤0.01% |
49,700
+31,200
| +169% | +$332K |
|
|
VRTU
2325
DELISTED
Virtusa Corporation
VRTU
| $548K | ﹤0.01% |
14,400
-5,500
| -28% | -$183K |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.